Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Bristol Myers Squibb Total Liabilities and Share Holders Equity 2010-2025 | BMY

Bristol Myers Squibb total liabilities and share holders equity from 2010 to 2025. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
  • Bristol Myers Squibb total liabilities and share holders equity for the quarter ending March 31, 2025 was $92.427B, a 6.67% decline year-over-year.
  • Bristol Myers Squibb total liabilities and share holders equity for 2024 was $92.603B, a 2.69% decline from 2023.
  • Bristol Myers Squibb total liabilities and share holders equity for 2023 was $95.159B, a 1.72% decline from 2022.
  • Bristol Myers Squibb total liabilities and share holders equity for 2022 was $96.82B, a 11.43% decline from 2021.
  
Bristol Myers Squibb Annual Total Liabilities and Share Holders Equity
(Millions of US $)
2024 $92,603
2023 $95,159
2022 $96,820
2021 $109,314
2020 $118,481
2019 $129,944
2018 $34,986
2017 $33,551
2016 $33,707
2015 $31,748
2014 $33,749
2013 $38,592
2012 $35,897
2011 $32,970
2010 $31,076
2009 $31,008
Bristol Myers Squibb Quarterly Total Liabilities and Share Holders Equity
(Millions of US $)
2025-03-31 $92,427
2024-12-31 $92,603
2024-09-30 $93,670
2024-06-30 $94,646
2024-03-31 $99,031
2023-12-31 $95,159
2023-09-30 $91,263
2023-06-30 $93,489
2023-03-31 $94,281
2022-12-31 $96,820
2022-09-30 $98,196
2022-06-30 $100,357
2022-03-31 $103,034
2021-12-31 $109,314
2021-09-30 $110,893
2021-06-30 $110,797
2021-03-31 $112,435
2020-12-31 $118,481
2020-09-30 $125,536
2020-06-30 $128,076
2020-03-31 $129,285
2019-12-31 $129,944
2019-09-30 $57,433
2019-06-30 $55,163
2019-03-31 $34,834
2018-12-31 $34,986
2018-09-30 $33,734
2018-06-30 $32,641
2018-03-31 $33,083
2017-12-31 $33,551
2017-09-30 $33,977
2017-06-30 $33,409
2017-03-31 $32,937
2016-12-31 $33,707
2016-09-30 $33,727
2016-06-30 $32,831
2016-03-31 $31,892
2015-12-31 $31,748
2015-09-30 $31,779
2015-06-30 $31,954
2015-03-31 $33,579
2014-12-31 $33,749
2014-09-30 $33,450
2014-06-30 $33,503
2014-03-31 $33,424
2013-12-31 $38,592
2013-09-30 $36,804
2013-06-30 $36,252
2013-03-31 $35,958
2012-12-31 $35,897
2012-09-30 $36,044
2012-06-30 $31,667
2012-03-31 $32,408
2011-12-31 $32,970
2011-09-30 $32,014
2011-06-30 $31,833
2011-03-31 $30,851
2010-12-31 $31,076
2010-09-30 $31,885
2010-06-30 $31,051
2010-03-31 $30,753
2009-12-31 $31,008
2009-09-30 $30,951
2009-06-30 $29,809
2009-03-31 $29,693
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $101.245B $48.300B
Bristol-Myers Squibb is a one of the leading global specialty biopharmaceutical companies focused on the development of treatments targeting serious diseases like cancer, inflammatory, immunologic, cardiovascular or fibrotic diseases. Backed by its blockbuster immuno-oncology drug, Opdivo, Bristol-Myers has a strong oncology portfolio, comprising other drugs like Revlimid, Pomalyst, Sprycel, Yervoy and Empliciti. It also has important immunology and cardiovascular drugs like Orencia and Eliquis. It's experiencing growth in both the Eliquis brand and the market, while also advancing its Factor XIa inhibitor program. After the sale of the global Diabetes business to AstraZeneca and the discontinuation of discovery research efforts in virology, it's focusing solely on research in core therapeutic areas like oncology, immuno-oncology, immunoscience, cardiovascular, fibrosis and genetically defined diseases. It acquried Celgene Corporation and MyoKardia. It received regulatory approvals for Reblozyl and Inrebic.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $230.797B 17.23
Amgen (AMGN) United States $158.742B 14.22
Gilead Sciences (GILD) United States $136.807B 14.21
Vertex Pharmaceuticals (VRTX) United States $116.958B 0.00
GSK (GSK) United Kingdom $83.746B 10.01
CSL (CSLLY) Australia $75.092B 0.00
Regeneron Pharmaceuticals (REGN) United States $57.139B 13.87
Alnylam Pharmaceuticals (ALNY) United States $40.158B 0.00
Argenex SE (ARGX) Netherlands $35.286B 96.32
BioNTech SE (BNTX) Germany $25.619B 0.00
Royalty Pharma (RPRX) United States $19.588B 8.28
Biogen (BIIB) United States $19.144B 8.26
Insmed (INSM) United States $17.983B 0.00
Genmab (GNMSF) Denmark $14.821B 15.16
Genmab (GMAB) Denmark $14.633B 16.42
Illumina (ILMN) United States $13.761B 26.11
Incyte (INCY) United States $13.114B 99.63
Swedish Orphan Biovitrum (BIOVF) Sweden $11.389B 29.08
Exelixis (EXEL) United States $11.342B 19.25
BioMarin Pharmaceutical (BMRN) United States $10.782B 17.51
QIAGEN (QGEN) Netherlands $10.472B 20.38
Ascendis Pharma (ASND) Denmark $10.434B 0.00
Moderna (MRNA) United States $10.314B 0.00
Exact Sciences (EXAS) United States $10.096B 0.00
Blueprint Medicines (BPMC) United States $8.264B 0.00
Bio-Techne Corp (TECH) United States $7.920B 29.54
Verona Pharma American Depositary Share (VRNA) United Kingdom $7.849B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $7.744B 0.00
Roivant Sciences (ROIV) United Kingdom $7.695B 0.00
Revolution Medicines (RVMD) United States $7.561B 0.00
Repligen (RGEN) United States $7.164B 80.20
Bio-Rad Laboratories (BIO.B) United States $6.805B 23.68
Legend Biotech (LEGN) United States $6.768B 0.00
Halozyme Therapeutics (HALO) United States $6.651B 12.73
Jazz Pharmaceuticals (JAZZ) Ireland $6.565B 6.45
Guardant Health (GH) United States $6.106B 0.00
TG Therapeutics (TGTX) United States $5.717B 150.04
Nuvalent (NUVL) United States $5.618B 0.00
Telix Pharmaceuticals (TLX) Australia $5.440B 0.00
Axsome Therapeutics (AXSM) United States $5.125B 0.00
Zealand Pharma (ZLDPF) Denmark $4.977B 0.00
ADMA Biologics Inc (ADMA) United States $4.968B 37.16
Alkermes (ALKS) Ireland $4.919B 13.20
Zai Lab (ZLAB) China $4.523B 0.00
Vaxcyte (PCVX) United States $4.458B 0.00
Akero Therapeutics (AKRO) United States $4.434B 0.00
Cytokinetics (CYTK) United States $4.106B 0.00
PTC Therapeutics (PTCT) United States $4.063B 7.07
Rhythm Pharmaceuticals (RYTM) United States $4.002B 0.00
Krystal Biotech (KRYS) United States $3.961B 30.53
Avidity Biosciences (RNA) United States $3.781B 0.00
Merus (MRUS) Netherlands $3.780B 0.00
Arcellx (ACLX) United States $3.637B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.633B 31.93
CRISPR Therapeutics AG (CRSP) Switzerland $3.572B 0.00
Sarepta Therapeutics (SRPT) United States $3.556B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.544B 0.00
SpringWorks Therapeutics (SWTX) United States $3.525B 0.00
Protagonist Therapeutics (PTGX) United States $3.494B 75.16
Metsera (MTSR) United States $3.087B 0.00
Scholar Rock Holding (SRRK) United States $3.081B 0.00
Kymera Therapeutics (KYMR) United States $3.058B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.946B 0.00
Alvotech (ALVO) Luxembourg $2.936B 16.79
Viking Therapeutics (VKTX) United States $2.929B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.830B 0.00
Ascentage Pharma Group - (AAPG) China $2.745B 0.00
ImmunityBio (IBRX) United States $2.710B 0.00
Immunovant (IMVT) United States $2.677B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.514B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.458B 0.00
Apellis Pharmaceuticals (APLS) United States $2.367B 0.00
Bavarian Nordic (BVNRY) Denmark $2.226B 11.76
Arrowhead Pharmaceuticals (ARWR) United States $2.174B 0.00
Ligand Pharmaceuticals (LGND) United States $2.171B 0.00
Vericel (VCEL) United States $2.148B 1422.33
Denali Therapeutics (DNLI) United States $2.114B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $2.065B 0.00
Apogee Therapeutics (APGE) United States $2.048B 0.00
Twist Bioscience (TWST) United States $2.008B 0.00
Agios Pharmaceuticals (AGIO) United States $1.986B 0.00
CG Oncology (CGON) United States $1.971B 0.00
NovoCure (NVCR) Jersey $1.957B 0.00
IDEAYA Biosciences (IDYA) United States $1.943B 0.00
Belite Bio (BLTE) United States $1.896B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.893B 12.58
Disc Medicine (IRON) United States $1.860B 0.00
Amicus Therapeutics (FOLD) United States $1.857B 201.00
Certara (CERT) United States $1.786B 33.36
Immunocore Holdings (IMCR) United Kingdom $1.742B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.718B 0.00
Beam Therapeutics (BEAM) United States $1.716B 0.00
Edgewise Therapeutics (EWTX) United States $1.609B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.601B 0.00
Biohaven (BHVN) United States $1.579B 0.00
Adaptive Biotechnologies (ADPT) United States $1.568B 0.00
89BIO (ETNB) United States $1.520B 0.00
Mesoblast (MESO) Australia $1.505B 0.00
GRAIL (GRAL) United States $1.486B 0.00
Janux Therapeutics (JANX) United States $1.473B 0.00
Vera Therapeutics (VERA) United States $1.450B 0.00
Celldex Therapeutics (CLDX) United States $1.411B 0.00
ANI Pharmaceuticals (ANIP) United States $1.355B 13.96
BGM Group (BGM) China $1.313B 0.00
Viridian Therapeutics (VRDN) United States $1.296B 0.00
Travere Therapeutics (TVTX) United States $1.288B 0.00
CureVac (CVAC) Germany $1.250B 6.05
Anbio Biotechnology (NNNN) Germany $1.246B 0.00
Structure Therapeutics (GPCR) United States $1.243B 0.00
Dynavax Technologies (DVAX) United States $1.233B 73.36
Liquidia Technologies (LQDA) United States $1.205B 0.00
MannKind (MNKD) United States $1.128B 23.19
Novavax (NVAX) United States $1.124B 2.62
Pacira BioSciences (PCRX) United States $1.122B 10.68
Niagen Bioscience (NAGE) United States $1.074B 151.44
WAVE Life Sciences (WVE) Singapore $1.071B 0.00
Spyre Therapeutics (SYRE) United States $1.042B 0.00
CorMedix Inc (CRMD) United States $0.988B 66.18
Arcus Biosciences (RCUS) United States $0.978B 0.00
Geron (GERN) United States $0.962B 0.00
AbCellera Biologics (ABCL) Canada $0.955B 0.00
Mineralys Therapeutics (MLYS) United States $0.933B 0.00
NeoGenomics (NEO) United States $0.910B 0.00
Nurix Therapeutics (NRIX) United States $0.910B 0.00
Praxis Precision Medicines (PRAX) United States $0.902B 0.00
MiMedx (MDXG) United States $0.892B 21.57
Syndax Pharmaceuticals (SNDX) United States $0.882B 0.00
Zymeworks (ZYME) United States $0.882B 0.00
Pharvaris (PHVS) Netherlands $0.873B 0.00
Intellia Therapeutics (NTLA) United States $0.861B 0.00
UniQure (QURE) Netherlands $0.840B 0.00
Oculis Holding AG (OCS) Switzerland $0.830B 0.00
Oric Pharmaceuticals (ORIC) United States $0.821B 0.00
LENZ Therapeutics (LENZ) United States $0.816B 0.00
Cogent Biosciences (COGT) United States $0.806B 0.00
Immunome (IMNM) United States $0.801B 0.00
ArriVent BioPharma (AVBP) United States $0.796B 0.00
Pharming Group (PHGUF) Netherlands $0.795B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.760B 0.00
Replimune (REPL) United States $0.754B 0.00
Gyre Therapeutics (GYRE) United States $0.749B 199.75
Iovance Biotherapeutics (IOVA) United States $0.748B 0.00
Immatics (IMTX) Germany $0.744B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.743B 0.00
Pharming Group (PHAR) Netherlands $0.731B 0.00
Sionna Therapeutics (SION) United States $0.723B 0.00
Vir Biotechnology (VIR) United States $0.722B 0.00
Trevi Therapeutics (TRVI) United States $0.714B 0.00
Anavex Life Sciences (AVXL) United States $0.686B 0.00
AnaptysBio (ANAB) United States $0.685B 0.00
Arbutus Biopharma (ABUS) United States $0.676B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.676B 0.00
GH Research (GHRS) Ireland $0.664B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Stoke Therapeutics (STOK) United States $0.630B 14.59
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.621B 0.00
Upstream Bio (UPB) United States $0.611B 0.00
Bicara Therapeutics (BCAX) United States $0.591B 0.00
Dianthus Therapeutics (DNTH) United States $0.589B 0.00
Nuvation Bio (NUVB) United States $0.589B 0.00
Maze Therapeutics (MAZE) United States $0.587B 0.00
Sana Biotechnology (SANA) United States $0.584B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.580B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.564B 0.00
Kura Oncology (KURA) United States $0.558B 0.00
Urogen Pharma (URGN) United States $0.555B 0.00
Tyra Biosciences (TYRA) United States $0.554B 0.00
Keros Therapeutics (KROS) United States $0.551B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.542B 0.00
Castle Biosciences (CSTL) United States $0.541B 36.76
Arvinas (ARVN) United States $0.539B 0.00
Fortrea Holdings (FTRE) United States $0.535B 14.77
MeiraGTx Holdings (MGTX) United States $0.533B 0.00
Opthea (OPT) Australia $0.525B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.523B 0.00
Tango Therapeutics (TNGX) United States $0.508B 0.00
Cullinan Therapeutics (CGEM) United States $0.508B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.494B 0.00
PureTech Health (PRTC) United States $0.471B 0.00
REGENXBIO (RGNX) United States $0.465B 0.00
Myriad Genetics (MYGN) United States $0.464B 0.00
ATyr Pharma (ATYR) United States $0.463B 0.00
Celcuity (CELC) United States $0.459B 0.00
Septerna (SEPN) United States $0.453B 0.00
Precigen (PGEN) United States $0.449B 0.00
Abivax SA (ABVX) France $0.443B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.439B 0.00
Benitec Biopharma (BNTC) United States $0.433B 0.00
Zenas BioPharma (ZBIO) United States $0.432B 0.00
Sage Therapeutics (SAGE) United States $0.420B 0.00
Erasca (ERAS) United States $0.419B 0.00
Tectonic Therapeutic (TECX) United States $0.409B 0.00
Rapport Therapeutics (RAPP) United States $0.408B 0.00
Cytek Biosciences (CTKB) United States $0.408B 0.00
Northwest Biotherapeutics (NWBO) United States $0.404B 0.00
Kamada (KMDA) Israel $0.396B 23.72
ITeos Therapeutics (ITOS) United States $0.389B 0.00
Eton Pharmaceuticals (ETON) United States $0.384B 0.00
Checkpoint Therapeutics (CKPT) United States $0.371B 0.00
Fulcrum Therapeutics (FULC) United States $0.370B 0.00
Humacyte (HUMA) United States $0.368B 0.00
Vigil Neuroscience (VIGL) United States $0.367B 0.00
Rezolute (RZLT) United States $0.359B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.355B 0.00
Absci (ABSI) United States $0.355B 0.00
Solid Biosciences (SLDB) United States $0.350B 0.00
MBX Biosciences (MBX) United States $0.347B 0.00
Emergent Biosolutions (EBS) United States $0.339B 0.00
Terns Pharmaceuticals (TERN) United States $0.339B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.336B 0.00
Compass Therapeutics (CMPX) United States $0.333B 0.00
Inventiva S.A (IVA) France $0.332B 0.00
Ocugen (OCGN) United States $0.330B 0.00
Astria Therapeutics (ATXS) United States $0.323B 0.00
Aura Biosciences (AURA) United States $0.323B 0.00
Abeona Therapeutics (ABEO) United States $0.315B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.313B 0.00
Verastem (VSTM) United States $0.308B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.302B 61.38
Zhengye Biotechnology Holding (ZYBT) China $0.299B 0.00
Allogene Therapeutics (ALLO) United States $0.293B 0.00
Alpha Teknova (TKNO) United States $0.293B 0.00
Entrada Therapeutics (TRDA) United States $0.288B 9.37
Cidara Therapeutics (CDTX) United States $0.287B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.286B 0.00
XOMA Royalty (XOMA) United States $0.285B 0.00
Olema Pharmaceuticals (OLMA) United States $0.285B 0.00
Gossamer Bio (GOSS) United States $0.282B 0.00
Neurogene (NGNE) United States $0.282B 0.00
Palvella Therapeutics (PVLA) United States $0.277B 0.00
Amarin (AMRN) Ireland $0.274B 0.00
Prothena (PRTA) Ireland $0.273B 0.00
Annexon (ANNX) United States $0.273B 0.00
Cartesian Therapeutics (RNAC) United States $0.270B 0.00
Atea Pharmaceuticals (AVIR) United States $0.270B 0.00
2seventy Bio (TSVT) United States $0.266B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.266B 0.00
Inozyme Pharma (INZY) United States $0.258B 0.00
Candel Therapeutics (CADL) United States $0.257B 0.00
Prima BioMed (IMMP) Australia $0.254B 0.00
Sagimet Biosciences (SGMT) United States $0.254B 0.00
Cardiff Oncology (CRDF) United States $0.253B 0.00
DBV Technologies S.A (DBVT) France $0.249B 0.00
Lifecore Biomedical (LFCR) United States $0.249B 0.00
Third Harmonic Bio (THRD) United States $0.245B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.243B 0.00
Foghorn Therapeutics (FHTX) United States $0.241B 0.00
MaxCyte (MXCT) United States $0.234B 0.00
Aardvark Therapeutics (AARD) United States $0.233B 0.00
Tvardi Therapeutics (TVRD) United States $0.230B 0.00
BioStem Technologies (BSEM) $0.230B 9.35
ACELYRIN, INC (SLRN) United States $0.229B 0.00
Semper Paratus Acquisition (TVGN) United States $0.228B 0.00
Instil Bio (TIL) United States $0.225B 0.00
CytomX Therapeutics (CTMX) United States $0.222B 5.73
Adherex Technologies (FENC) United States $0.219B 0.00
Design Therapeutics (DSGN) United States $0.218B 0.00
Adocia (ADOCY) France $0.213B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.213B 0.00
Inhibrx Biosciences (INBX) United States $0.211B 0.12
ScPharmaceuticals (SCPH) United States $0.209B 0.00
GENFIT S.A (GNFT) France $0.205B 0.00
Monopar Therapeutics (MNPR) United States $0.205B 0.00
Kodiak Sciences (KOD) United States $0.205B 0.00
I-Mab (IMAB) United States $0.203B 0.00
CARGO Therapeutics (CRGX) United States $0.202B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.198B 0.00
AC Immune (ACIU) Switzerland $0.196B 0.00
Bright Minds Biosciences (DRUG) United States $0.194B 0.00
Prime Medicine (PRME) United States $0.192B 0.00
Codexis (CDXS) United States $0.185B 0.00
Voyager Therapeutics (VYGR) United States $0.183B 0.00
Ventyx Biosciences (VTYX) United States $0.182B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.181B 0.00
INmune Bio (INMB) United States $0.177B 0.00
Nuvectis Pharma (NVCT) United States $0.176B 0.00
Innate Pharma S.A (IPHA) France $0.175B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.172B 0.00
EnGene Holdings (ENGN) Canada $0.170B 0.00
Actuate Therapeutics (ACTU) United States $0.170B 0.00
Puma Biotechnology (PBYI) United States $0.166B 4.35
Galena Biopharma (SLS) United States $0.166B 0.00
Editas Medicine (EDIT) United States $0.165B 0.00
BioAge Labs (BIOA) United States $0.162B 0.00
Spero Therapeutics (SPRO) United States $0.158B 0.00
Anika Therapeutics (ANIK) United States $0.157B 0.00
DiaMedica Therapeutics (DMAC) United States $0.157B 0.00
Molecular Partners AG (MOLN) Switzerland $0.155B 0.00
Alector (ALEC) United States $0.154B 0.00
Alpha Cognition (ACOG) Canada $0.150B 0.00
Alumis (ALMS) United States $0.148B 0.00
23andMe Holding (MEHCQ) United States $0.147B 0.00
Compugen (CGEN) Israel $0.146B 0.00
Fate Therapeutics (FATE) United States $0.146B 0.00
Kyverna Therapeutics (KYTX) United States $0.139B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.139B 0.00
Rapt Therapeutics (RAPT) United States $0.138B 0.00
Neumora Therapeutics (NMRA) United States $0.137B 0.00
Nkarta (NKTX) United States $0.132B 0.00
Black Diamond Therapeutics (BDTX) United States $0.131B 38.50
Agenus (AGEN) United States $0.129B 0.00
Greenwich LifeSciences (GLSI) United States $0.123B 0.00
Seer (SEER) United States $0.122B 0.00
Elicio Therapeutics (ELTX) United States $0.122B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.120B 0.00
C4 Therapeutics (CCCC) United States $0.119B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.118B 0.00
BioHarvest Sciences (BHST) Canada $0.118B 0.00
Genelux (GNLX) United States $0.115B 0.00
Contineum Therapeutics (CTNM) United States $0.115B 0.00
Sangamo Therapeutics (SGMO) United States $0.114B 0.00
Theratechnologies (THTX) Canada $0.114B 0.00
BeyondSpring (BYSI) United States $0.112B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.108B 0.00
TuHURA Biosciences (HURA) United States $0.107B 0.00
EXoZymes (EXOZ) United States $0.107B 0.00
Citius Oncology (CTOR) United States $0.105B 0.00
Caribou Biosciences (CRBU) United States $0.103B 0.00
OKYO Pharma (OKYO) $0.102B 0.00
Cabaletta Bio (CABA) United States $0.101B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.096B 0.00
Tenaya Therapeutics (TNYA) United States $0.096B 0.00
Invivyd (IVVD) United States $0.095B 0.00
Coya Therapeutics (COYA) United States $0.094B 0.00
HilleVax (HLVX) United States $0.093B 0.00
Whitehawk Therapeutics (WHWK) United States $0.092B 0.00
Adagene (ADAG) China $0.092B 0.00
IO Biotech (IOBT) Denmark $0.089B 0.00
Biomea Fusion (BMEA) United States $0.089B 0.00
Nautilus Biotechnology (NAUT) United States $0.088B 0.00
Coherus Oncology (CHRS) United States $0.088B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.088B 0.00
TScan Therapeutics (TCRX) United States $0.088B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.086B 0.00
Climb Bio (CLYM) United States $0.085B 0.00
Pliant Therapeutics (PLRX) United States $0.085B 0.00
Entera Bio (ENTX) Israel $0.085B 0.00
Jasper Therapeutics (JSPR) United States $0.084B 0.00
Zura Bio (ZURA) United States $0.082B 0.00
XBiotech (XBIT) United States $0.080B 0.00
PDS Biotechnology (PDSB) United States $0.080B 0.00
Forte Biosciences (FBRX) United States $0.080B 0.00
Immunic (IMUX) United States $0.077B 0.00
Cellectis S.A (CLLS) France $0.074B 0.00
Inovio Pharmaceuticals (INO) United States $0.073B 0.00
Elutia (ELUT) United States $0.073B 0.00
IGM Biosciences (IGMS) United States $0.072B 0.00
Genenta Science S.p.A (GNTA) Italy $0.071B 0.00
Immuneering (IMRX) United States $0.068B 0.00
Senti Biosciences (SNTI) United States $0.068B 0.00
Sutro Biopharma (STRO) United States $0.067B 0.00
TELA Bio (TELA) United States $0.067B 0.00
Immix Biopharma (IMMX) United States $0.066B 0.00
Seres Therapeutics (MCRB) United States $0.065B 0.00
Alto Neuroscience (ANRO) United States $0.065B 0.00
MediciNova (MNOV) United States $0.065B 0.00
Ikena Oncology (IKNA) United States $0.065B 0.00
Quince Therapeutics (QNCX) United States $0.065B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.065B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.064B 0.00
VistaGen Therapeutics (VTGN) United States $0.064B 0.00
Skye Bioscience (SKYE) United States $0.064B 0.00
Repare Therapeutics (RPTX) Canada $0.063B 0.00
Renovaro (RENB) United States $0.063B 0.00
Clearside Biomedical (CLSD) United States $0.062B 0.00
Adicet Bio (ACET) United States $0.062B 0.00
CervoMed (CRVO) United States $0.062B 0.00
Akoya Biosciences (AKYA) United States $0.061B 0.00
Oncobiologics (OTLK) United States $0.061B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.061B 0.00
Adlai Nortye (ANL) Cayman Islands $0.060B 0.00
Opus Genetics (IRD) United States $0.058B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.057B 0.00
Exicure (XCUR) United States $0.055B 0.00
Annovis Bio (ANVS) United States $0.055B 0.00
Werewolf Therapeutics (HOWL) United States $0.055B 0.00
Fortress Biotech (FBIO) United States $0.055B 0.00
Kronos Bio (KRON) United States $0.054B 0.00
Precision BioSciences (DTIL) United States $0.054B 0.00
ZIVO Bioscience (ZIVO) United States $0.053B 0.00
Quantum Biopharma (QNTM) Canada $0.053B 0.00
Connect Biopharma Holdings (CNTB) United States $0.053B 0.00
Oncolytics Biotech (ONCY) Canada $0.053B 0.00
InflaRx (IFRX) Germany $0.053B 0.00
Atara Biotherapeutics (ATRA) United States $0.053B 0.00
Adverum Biotechnologies (ADVM) United States $0.051B 0.00
Applied Therapeutics (APLT) United States $0.050B 0.00
Kalaris Therapeutics (KLRS) United States $0.049B 0.00
VTv Therapeutics (VTVT) United States $0.049B 0.00
Bluebird Bio (BLUE) United States $0.049B 0.00
Shattuck Labs (STTK) United States $0.048B 0.00
Artiva Biotherapeutics (ARTV) United States $0.048B 0.00
RenovoRx (RNXT) United States $0.048B 0.00
Aligos Therapeutics (ALGS) United States $0.047B 0.00
PepGen (PEPG) United States $0.047B 0.00
Mersana Therapeutics (MRSN) United States $0.046B 0.00
Cue Biopharma (CUE) United States $0.045B 0.00
Celularity (CELU) United States $0.042B 0.00
Rein Therapeutics (RNTX) United States $0.042B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.039B 0.00
Alterity Therapeutics - (ATHE) Australia $0.039B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.038B 0.00
Radiopharm Theranostics - (RADX) Australia $0.038B 0.00
Clene (CLNN) United States $0.037B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.036B 0.00
OnKure Therapeutics (OKUR) United States $0.036B 0.00
Medicus Pharma (MDCX) United States $0.035B 0.00
Estrella Immunopharma (ESLA) United States $0.035B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.034B 0.00
Pluri (PLUR) Israel $0.034B 0.00
Xilio Therapeutics (XLO) United States $0.034B 0.00
Kezar Life Sciences (KZR) United States $0.034B 0.00
Scilex Holding (SCLX) United States $0.034B 0.00
Lantern Pharma (LTRN) United States $0.033B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.033B 0.00
AN2 Therapeutics (ANTX) United States $0.032B 0.00
CAMP4 Therapeutics (CAMP) United States $0.031B 0.00
FibroBiologics (FBLG) United States $0.031B 0.00
Rani Therapeutics Holdings (RANI) United States $0.030B 0.00
ABVC BioPharma (ABVC) United States $0.030B 0.00
Allakos (ALLK) United States $0.030B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.029B 0.00
MiNK Therapeutics (INKT) United States $0.029B 0.00
Grace Therapeutics (GRCE) Canada $0.029B 0.00
Dyadic (DYAI) United States $0.028B 0.00
KALA BIO (KALA) United States $0.028B 0.00
ALX Oncology Holdings (ALXO) United States $0.027B 0.00
Cadrenal Therapeutics (CVKD) United States $0.027B 0.00
Dare Bioscience (DARE) United States $0.027B 0.00
Curis (CRIS) United States $0.026B 0.00
Imunon (IMNN) United States $0.025B 0.00
Generation Bio (GBIO) United States $0.025B 0.00
Passage Bio (PASG) United States $0.024B 0.00
CalciMedica (CALC) United States $0.024B 0.00
BioAtla (BCAB) United States $0.024B 0.00
Tenax Therapeutics (TENX) United States $0.024B 0.00
Boundless Bio (BOLD) United States $0.024B 0.00
Vor Biopharma (VOR) $0.023B 0.00
Femasys (FEMY) United States $0.023B 0.00
Chemomab Therapeutics (CMMB) Israel $0.023B 0.00
Elevation Oncology (ELEV) United States $0.023B 0.00
Lisata Therapeutics (LSTA) United States $0.022B 0.00
Advanced Biomed (ADVB) United States $0.021B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.020B 0.00
Q32 Bio (QTTB) United States $0.020B 0.00
Ovid Therapeutics (OVID) United States $0.020B 0.00
Gelteq (GELS) Australia $0.020B 0.00
Longeveron (LGVN) United States $0.019B 0.00
NextCure (NXTC) United States $0.019B 0.00
Cognition Therapeutics (CGTX) United States $0.018B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.018B 0.00
Cingulate (CING) United States $0.018B 0.00
HOOKIPA Pharma (HOOK) United States $0.017B 0.00
Hoth Therapeutics (HOTH) United States $0.017B 0.00
Lexaria Bioscience (LEXX) Canada $0.017B 0.00
Leap Therapeutics (LPTX) United States $0.017B 0.00
Promis Neurosciences (PMN) Canada $0.017B 0.00
X4 Pharmaceuticals (XFOR) United States $0.016B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.016B 0.00
SAB Biotherapeutics (SABS) United States $0.016B 0.00
GeoVax Labs (GOVX) United States $0.016B 0.00
Beyond Air (XAIR) United States $0.015B 0.00
IBio (IBIO) United States $0.015B 0.00
Synlogic (SYBX) United States $0.015B 0.00
MetaVia (MTVA) United States $0.014B 0.00
UNITY Biotechnology (UBX) United States $0.014B 0.00
Edesa Biotech (EDSA) Canada $0.013B 0.00
Rallybio (RLYB) United States $0.013B 0.00
Abpro Holdings (ABP) United States $0.013B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.013B 0.00
Biorestorative Therapies (BRTX) United States $0.013B 0.00
Equillium (EQ) United States $0.012B 0.00
Bionano Genomics (BNGO) United States $0.012B 0.00
Allarity Therapeutics (ALLR) United States $0.012B 0.00
Aytu BioPharma (AYTU) United States $0.012B 0.00
Athira Pharma (ATHA) United States $0.012B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.012B 0.00
Bolt Biotherapeutics (BOLT) United States $0.012B 0.00
BRIACELL THERAP (BCTX) Canada $0.012B 0.00
BioCardia (BCDA) United States $0.011B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
Aprea Therapeutics (APRE) United States $0.010B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
Cyclerion Therapeutics (CYCN) United States $0.010B 0.00
BioXcel Therapeutics (BTAI) United States $0.009B 0.00
Novogen (KZIA) Australia $0.009B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.009B 0.00
Moleculin Biotech (MBRX) United States $0.009B 0.00
Dogwood Therapeutics (DWTX) United States $0.009B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.009B 0.00
LakeShore Biopharma (LSB) China $0.009B 0.00
GENPREX (GNPX) United States $0.008B 0.00
BioAffinity Technologies (BIAF) United States $0.008B 0.00
HCW Biologics (HCWB) United States $0.008B 0.00
Turnstone Biologics (TSBX) United States $0.008B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.008B 0.00
Sensei Biotherapeutics (SNSE) United States $0.008B 0.00
Evogene (EVGN) Israel $0.007B 0.00
GT Biopharma (GTBP) United States $0.007B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.007B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.007B 0.00
Sunshine Biopharma (SBFM) United States $0.007B 0.00
Eyenovia (EYEN) United States $0.007B 0.00
IN8bio (INAB) United States $0.007B 0.00
Arcadia Biosciences (RKDA) United States $0.007B 0.00
Apollomics (APLM) United States $0.007B 0.00
Mainz Biomed (MYNZ) Germany $0.006B 0.00
Portage Biotech (PRTG) $0.006B 0.00
Biofrontera (BFRI) United States $0.006B 0.00
Avalon GloboCare (ALBT) United States $0.006B 0.00
Soligenix (SNGX) United States $0.006B 0.00
Intensity Therapeutics (INTS) United States $0.006B 0.00
Pasithea Therapeutics (KTTA) United States $0.006B 0.00
Jade Biosciences (JBIO) United States $0.006B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.006B 0.00
180 Life Sciences (ATNF) United States $0.006B 0.00
Synaptogenix (SNPX) United States $0.005B 0.00
Mustang Bio (MBIO) United States $0.005B 0.00
Ensysce Biosciences (ENSC) United States $0.005B 0.00
Dermata Therapeutics (DRMA) United States $0.005B 0.00
Polyrizon (PLRZ) Israel $0.004B 0.00
Galecto (GLTO) Denmark $0.004B 0.00
CNS Pharmaceuticals (CNSP) United States $0.004B 0.00
VivoSim Labs (VIVS) United States $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.004B 0.00
Onconetix (ONCO) United States $0.004B 0.00
Tharimmune (THAR) United States $0.003B 0.00
Purple Biotech (PPBT) Israel $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Palisade Bio (PALI) United States $0.003B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
Affimed (AFMD) Germany $0.003B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.003B 0.00
GRI Bio (GRI) United States $0.003B 0.00
Adial Pharmaceuticals (ADIL) United States $0.003B 0.00
Silo Pharma (SILO) United States $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Alzamend Neuro (ALZN) United States $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.003B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.002B 0.00
Atrinsic (PTIX) United States $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Revelation Biosciences (REVB) United States $0.001B 0.00
NuCana (NCNA) United Kingdom $0.001B 0.00
Capstone Holding� (CAPS) United States $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Cocrystal Pharma (COCP) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00